Okla. Stat. tit. 63, § 63-2-801: Definitions

As used in this act:

1. "Academic medical center" means a medical school and its

affiliated teaching hospitals and clinics in this state that:

a. operate a medical residency program for physicians,

and

b. conduct research that is overseen by the federal

Department of Health and Human Services and involves

human subjects;

2. "Approved source" means a provider approved by the United

States Food and Drug Administration which produces cannabidiol that:

a. has been manufactured and tested in a facility

approved or certified by the United States Food and

Drug Administration or similar national regulatory

agency in another country which has been approved by

the United States Food and Drug Administration, and

b. has been tested on animals to demonstrate preliminary

effectiveness and to ensure that it is safe to

administer to humans;

3. "Cannabidiol" means a nonpsychoactive cannabinoid found in

the plant Cannabis sativa L. or any other preparation thereof, that

has a tetrahydrocannabinol concentration of not more than three-

tenths of one percent (0.3%) and that is delivered to the patient in

the form of a liquid;

4. "Physician" means a doctor of medicine or doctor of

osteopathic medicine licensed by the State Board of Medical

Licensure and Supervision or the State Board of Osteopathic

Examiners; and

5. "Qualifying patient" means any person who suffers from

Lennox-Gastaut Syndrome, Dravet Syndrome, also known as Severe

Myoclonic Epilepsy of Infancy, or any other form of refractory

epilepsy that is not adequately treated by traditional medical

therapies.